AlessiaFornoniMDPhD FASN

Summary

• Dr. Fornoni is tenured Professor of Medicine and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She is the Chief of the Katz Family Division of Nephrology and Hypertension and serves as and Director and Chair of the Peggy and Harold Katz Drug Discovery Center. She is also the Associate Director of the MSTP program and the Co-Director of the CTSI/KL2 program. In the year 2013, Dr. Fornoni gained experience in drug development as Global Head of Discovery in Cardiovascular and Metabolism at Hoffman-La Roche in Basel. She funded several start up companies focused on finding a cure for patients affected by chronic kidney diseases.
  As a physician-scientist who has maintained a resolutely focused research program that has provided novel and seminal contributions to our understanding of the pathogenesis of kidney disease, her research is supported by grants from National Institutes of Health, industry and private foundations. She has received prestigious awards: among them, she is the first female nephrologist in the history of the University of Miami to become a member of ASCI. She serves or have served on the editorial board of the Journal of Clinical Investigation, Diabetes and Kidney International. She was visiting professor at more than 50 academic institutions and international meetings worldwide. She serves and have served on the advisory board of more than 20 companies. Her contributions have been published in high impact journals: Journal of Clinical Investigation, NEJM, Nature Medicine, Cell Metabolism, Science Translational Medicine, Nature Communication, among others. Her trainees are occupying key academic and industry positions in five different continents worldwide. Moving forward, her vision is one that brings industry, investors and not for profit organizations around the table with the intent to match science with innovation and patients’ motivation to find a cure for kidney diseases.